Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
Cancer Research Institute · UPMC Hillman Cancer Center · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,182
total citations
- FWCI
- 13.95
- Percentile
- 100%
- References
- 50
Citations per year
Authors
14- MCMichael C. MiloneCorresponding
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
- JDJonathan D. Fish
Children's Hospital of Philadelphia, University of Pennsylvania
- CCCarmine Carpenito
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
- RGRichard G. Carroll
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
- GKGwendolyn K. Binder
Cancer Research Institute, UPMC Hillman Cancer Center, University of Pennsylvania
Topics & keywords
Topics
Keywords
- CD137
- Chimeric antigen receptor
- CD28
- CD19
- T-cell receptor
- Biology
- Cancer research
- Receptor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.